NEW YORK, March 5, 2012 /PRNewswire/ -- Organovo,
Inc., (OTCQB: ONVO) the San
Diego-based regenerative medicine company focused on using
its breakthrough NovoGen 3D human tissue printing technology to
create tissue on demand for research and medical applications,
today announced that their March 1st
RetailInvestorConferences.com presentation is now available for
on-demand viewing.
LINK: www.retailinvestorconferences.com >
red "register/ watch event now" button
Organovo, Inc.'s presentation will be available 24/7 for 90
days. Investors may download shareholder materials from the
"virtual trade booth" for the next three weeks.
About Organovo, Inc.:
Organovo (OTCQB: ONVO) is a three-dimensional biology company
focused on delivering breakthrough bioprinting technology and
creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a
platform that works across all tissue and cell types. Organovo's
NovoGen MMX Bioprinter™ was selected as one of the
"Best Inventions of 2010" by TIME Magazine. Organovo is helping
pharmaceutical partners develop human biological disease models in
three dimensions that enable therapeutic drug discovery and
development. Organovo's bioprinting technology can also be
developed to create surgical tissues direct therapy. Organovo leads
the way in solving complex medical research problems and building
the future of medicine. For more information, please visit
http://www.organovo.com.
About RetailInvestorConferences.com:
Since 2010, RetailInvestorConferences.com, created by
BetterInvesting (NAIC), PR Newswire and MUNCmedia, has
been the only monthly virtual investor conference series that
provides an interactive forum for presenting companies to meet
directly with retail investors using a graphically-enhanced online
platform.
Designed to replicate the look and feel of location-based
investor conferences, Retail Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor
communications capabilities with BetterInvesting's extensive retail
investor audience network and MUNCmedia's sophisticated retail
investor targeting.
SOURCE Organovo, Inc.